Insights

Innovative Technology Medincell's proprietary BEPO® technology for long-acting injectables presents a compelling opportunity for firms focused on advanced drug delivery solutions, particularly those seeking to enhance patient compliance and reduce environmental impact.

Strategic Collaborations The company's recent partnerships with industry leaders like AbbVie and Teva indicate a strong pipeline of next-generation therapies, offering potential avenues for joint development, licensing, or pharmaceutical distribution partnerships.

Expanding Market Presence Participation in major global healthcare conferences and the appointment of a Chief Strategy Officer for U.S. operations suggest Medincell is scaling its market outreach, providing opportunities to engage with their expanding healthcare network and distribution channels.

Financial Growth Opportunity With recent funding of $57 million and a revenue range of $1 million to $10 million, Medincell is positioned for growth, making it a viable partner for supply chain solutions, manufacturing services, or investment collaborations.

Focus on Global Health Medincell’s mission to improve global health through accessible and sustainable therapies aligns with the values of organizations aiming to expand innovative healthcare solutions worldwide, presenting potential market expansion and partnership opportunities.

MedinCell Tech Stack

MedinCell uses 8 technology products and services including Cookie Notice, Mailjet, Font Awesome, and more. Explore MedinCell's tech stack below.

  • Cookie Notice
    Cookie Compliance
  • Mailjet
    Email
  • Font Awesome
    Font Scripts
  • Windows Server
    Operating Systems
  • PHP
    Programming Languages
  • Linux
    Programming Languages
  • X-XSS-Protection
    Security
  • Piwik PRO Core
    Web Analytics

Media & News

MedinCell's Email Address Formats

MedinCell uses at least 1 format(s):
MedinCell Email FormatsExamplePercentage
First.Last@medincell.comJohn.Doe@medincell.com
50%
First.Last@medincell.comJohn.Doe@medincell.com
50%

Frequently Asked Questions

What is MedinCell's phone number?

Minus sign iconPlus sign icon
You can contact MedinCell's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MedinCell's stock symbol?

Minus sign iconPlus sign icon
MedinCell is a publicly traded company; the company's stock symbol is MEDCL.PA.

What is MedinCell's official website and social media links?

Minus sign iconPlus sign icon
MedinCell's official website is medincell.com and has social profiles on LinkedInCrunchbase.

What is MedinCell's SIC code NAICS code?

Minus sign iconPlus sign icon
MedinCell's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does MedinCell have currently?

Minus sign iconPlus sign icon
As of December 2025, MedinCell has approximately 162 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: C. D.Chief Business Officer: S. E.Chief Strategy Officer, U.S. Finance: G. K.. Explore MedinCell's employee directory with LeadIQ.

What industry does MedinCell belong to?

Minus sign iconPlus sign icon
MedinCell operates in the Pharmaceutical Manufacturing industry.

What technology does MedinCell use?

Minus sign iconPlus sign icon
MedinCell's tech stack includes Cookie NoticeMailjetFont AwesomeWindows ServerPHPLinuxX-XSS-ProtectionPiwik PRO Core.

What is MedinCell's email format?

Minus sign iconPlus sign icon
MedinCell's email format typically follows the pattern of First.Last@medincell.com. Find more MedinCell email formats with LeadIQ.

How much funding has MedinCell raised to date?

Minus sign iconPlus sign icon
As of December 2025, MedinCell has raised $57M in funding. .

When was MedinCell founded?

Minus sign iconPlus sign icon
MedinCell was founded in 2002.

MedinCell

Pharmaceutical ManufacturingOccitanie, France51-200 Employees

Better Medicine for All

MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. 
Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. 
We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options.

Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition for achieving our objectives.

#BetterMedicineForAll #ImpactHealth #GlobalHealth #ControlledRelease #CreativeThinking #InnovationForward #Science

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
MEDCL.PA
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2002
Employees
51-200

Section iconFunding & Financials

  • $57M

    MedinCell has raised a total of $57M of funding over 3 rounds. .

  • $1M$10M

    MedinCell's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $57M

    MedinCell has raised a total of $57M of funding over 3 rounds. .

  • $1M$10M

    MedinCell's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.